• Pharmacological properties

    Pharmacological properties
     

    Figure © Sanofi.

     

    Data based on PK/PD studies may not always correlate with clinical efficacy

    PRALUENT ADMINISTRATION

    Learn more

    PRALUENT® MECHANISM OF ACTION

    Learn more
    1. Praluent® (alirocumab) European Summary of Product Characteristics. March 2019.
    2. Kuhnast S, et al. J Lipid Res 2014;55:2103–2112.